Comment from Empower Pharmacy

Summary: Empower Pharmacy, the nation's largest compounding pharmacy, supports the inclusion of seven specific bulk drug substances (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, and Epitalon) on the Section 503A Bulks List. They argue that these substances lack approved drug equivalents and that providing a regulated pathway for their use is safer for patients than the current unregulated gray market.